Literature DB >> 17295717

Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non-pediatric setting.

R Mohanraj1, M J Brodie.   

Abstract

INTRODUCTION: The prognosis of idiopathic generalized epilepsy syndromes (IGES) in the adult setting may vary from that in children owing to differences in genetic, environmental and lifestyle factors.
METHODS: All patients diagnosed with epilepsy at the Epilepsy Unit, Western Infirmary, Glasgow, between 1981 and 2001 were reviewed.
RESULTS: Of 890 patients, 118 (13%) met the criteria for IGES. Outcomes were known for 103, 66 (64%) of whom achieved remission. The responder rate with sodium valproate was superior (66% vs 45%, P = 0.073) to that with lamotrigine (LTG) particularly in patients with juvenile myoclonic epilepsies (75% vs 39%, P = 0.014). History of febrile seizures was the only factor associated with reduced likelihood of remission (P = 0.032)
CONCLUSIONS: Idiopathic generalized epilepsy syndromes constituted 13% of cases in a largely adult cohort of newly diagnosed epilepsy, most of whom achieved remission usually with a single antiepileptic drug. History of febrile seizures was associated with a poorer outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295717     DOI: 10.1111/j.1600-0404.2006.00791.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

Review 1.  Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Authors:  Arife Çimen Atalar; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

Review 2.  Genetic generalized epilepsies in adults - challenging assumptions and dogmas.

Authors:  Bernd J Vorderwülbecke; Britta Wandschneider; Yvonne Weber; Martin Holtkamp
Journal:  Nat Rev Neurol       Date:  2021-11-26       Impact factor: 42.937

3.  Prognostic value of EEG asymmetries for development of drug-resistance in drug-naïve patients with genetic generalized epilepsies.

Authors:  Ioannis Karakis; Jay S Pathmanathan; Richard Chang; E Francis Cook; Sydney S Cash; Andrew J Cole
Journal:  Clin Neurophysiol       Date:  2013-10-01       Impact factor: 3.708

Review 4.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

5.  Valproate in children with newly diagnosed idiopathic generalized epilepsy.

Authors:  K D Holland; S Monahan; D Morita; G Vartzelis; T A Glauser
Journal:  Acta Neurol Scand       Date:  2010-01-06       Impact factor: 3.209

6.  Racial and ethnic differences in epilepsy classification among probands in the Epilepsy Phenome/Genome Project (EPGP).

Authors:  Daniel Friedman; Robyn Fahlstrom
Journal:  Epilepsy Res       Date:  2013-10-01       Impact factor: 3.045

7.  Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study.

Authors:  G Mawer; M Briggs; G A Baker; R Bromley; H Coyle; J Eatock; L Kerr; U Kini; L Kuzmyshcheva; S B Lucas; L Wyatt; J Clayton-Smith
Journal:  Seizure       Date:  2009-12-24       Impact factor: 3.184

8.  EEG correlates of seizure freedom in genetic generalized epilepsies.

Authors:  Udaya Seneviratne; Ray C Boston; Mark Cook; Wendyl D'Souza
Journal:  Neurol Clin Pract       Date:  2017-02

Review 9.  Recent Advances in Neuroimaging of Epilepsy.

Authors:  Adam M Goodman; Jerzy P Szaflarski
Journal:  Neurotherapeutics       Date:  2021-05-03       Impact factor: 7.620

10.  Development and validation of a predictive model of drug-resistant genetic generalized epilepsy.

Authors:  Hyunmi Choi; Kamil Detyniecki; Carl Bazil; Suzanne Thornton; Peter Crosta; Hatem Tolba; Manahil Muneeb; Lawrence J Hirsch; Erin L Heinzen; Arjune Sen; Chantal Depondt; Piero Perucca; Gary A Heiman
Journal:  Neurology       Date:  2020-08-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.